ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sandoz Recalls One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping
December 09, 2021Sandoz Inc. is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature excursion during shipment. Enoxaparin.
Pharma Sources Insight January 2025
